Posts with tag Pharmaceuticals

Sort by Latest
New Draft Implementing Regulations propose key changes for pharmaceuticals in China
On 9 May 2022, the National Medical Products Administration (the “NMPA”) published the Implementing Regulations of the Drug Administration Law (Draft Amendments) (the “Draft Regulations”) for public consultation which will last until 9 June 2022.  The Draft Regulations propose significant changes to the current Implementing Regulations of the Drug Administration Law (2019) (the “Current Regulations”). The Draft Regulations provide a comprehensive regulatory framework governing the entire lifecycle...
May 19, 2022
5 min read
Spanish courts say “no” to the evergreening on data exclusivity of medicines.
Three recent judgments handed down by the Central Administrative Courts Nos. 4, 10 and 2 on 30 March,...
June 14, 2021
8 min read
First medicinal cannabis drug listed on the Australian Pharmaceuticals Benefits Scheme
On 1 May 2021 Epidyolex, the first medicinal cannabis drug product was listed on the Pharmaceutical Benefits...
May 6, 2021
1 min read
EU merger control – new guidance brings uncertainty – particularly for tech and pharma acquisitions
Illumina’s acquisition of cancer testing startup, Grail, looks set to be the testing ground for the Commission’s...
April 20, 2021
7 min read
Chinese patent linkage system – the Chinese Supreme Court issues Draft Judicial Interpretations
The Chinese Supreme Court (“SPC”) released on 29 October 2020 the “Provisions on Several...
November 13, 2020
6 min read
Australian Courts apply “European Support” test to find key Wyeth’s Prevnar 13 patent invalid
In the recent decision in the Australian front of the Prevnar 13 patent litigation, Merck...
November 4, 2020
10 min read
Cookie consent
We use analytics cookies to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential to make our website work. You can accept or reject our analytic cookies (including the collection of associated data) and change your mind at any time. Find out more in our Cookie Notice.